SCHEMBL22306175

SCHEMBL22306175

Cn1ccc(C(=O)NCC(O)Nc2nc(-c3ccc4c(c3)OCC4)cs2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 12/20 0.47
▸ SMN1; SMN2 Q16637 12/20 0.47
▸ NPC1 O15118 11/20 0.47
▸ MAPT P10636 11/20 0.42
▸ ALDH1A1 P00352 7/20 0.42
▸ LMNA P02545 6/20 0.42
▸ NFKB1 P19838 3/20 0.42
▸ NFKB2 Q00653 3/20 0.42
▸ RELA Q04206 3/20 0.42
▸ KMT2A Q03164 10/20 0.41
▸ MEN1 O00255 9/20 0.41
▸ GAA P10253 1/20 0.41
▸ KDM4E B2RXH2 4/20 0.41
▸ CLK1 P49759 2/20 0.41
▸ POLB P06746 2/20 0.38
▸ HTT P42858 1/20 0.38
▸ TSHR P16473 3/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ GSTO1 P78417 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22306207 0.75 RAB9A (0.65) RAB9ASMN1; SMN2NPC1MAPTALDH1A1
SCHEMBL22305505 0.74 SMARCA2 (0.38) RAB9ANPC1MAPTALDH1A1KDM4E
SCHEMBL22306193 0.71 RAB9A (0.46) RAB9ASMN1; SMN2NPC1MAPTALDH1A1
SCHEMBL22306344 0.71 RAB9A (0.52) RAB9ASMN1; SMN2NPC1MAPTALDH1A1
SCHEMBL22971623 0.70 RAB9A (0.52) RAB9ASMN1; SMN2NPC1MAPTALDH1A1
SCHEMBL22306176 0.69 RAB9A (0.41) RAB9ASMN1; SMN2NPC1MAPTALDH1A1
SCHEMBL22306232 0.69 SMARCA2 (0.49) RAB9ASMN1; SMN2NPC1MAPTALDH1A1
SCHEMBL22305753 0.68 SMARCA2 (0.57) RAB9ASMN1; SMN2NPC1MAPTALDH1A1
SCHEMBL2556662 0.66 RAB9A (0.66) RAB9ASMN1; SMN2NPC1MAPTALDH1A1
SCHEMBL22305368 0.65 MAPT (0.49) RAB9ASMN1; SMN2NPC1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020160180-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2020-08-06 — — WO disclosed
Send feedback